Drug intelligence / Profile preview

Vicryl Plus + Monocryl Plus + PDS Plus

Development stage
Unknown
Lead developer
Ethicon
Modality
Small Molecules
Administration
Implant
01

Overview

Vicryl Plus + Monocryl Plus + PDS Plus is a combination of three triclosan-coated absorbable surgical sutures manufactured by Ethicon, a Johnson & Johnson company. The combination includes Coated VICRYL Plus (polyglactin 910, a multifilament), MONOCRYL Plus (poliglecaprone 25, a monofilament), and PDS Plus (polydioxanone, a monofilament). Each suture is impregnated or coated with triclosan (Irgacare MP), a medical-grade antimicrobial agent designed to inhibit bacterial colonization, particularly by Gram-positive organisms such as *Staphylococcus aureus*, for up to approximately 30 days post-implantation. This combination is classified as a medical device/drug combination and is used for general soft tissue approximation and ligation. In clinical research, such as the Phase 4 trial conducted by the University of Texas Medical Branch, this combination has been evaluated for its efficacy in reducing surgical site infections (SSI) and endometritis in patients undergoing cesarean delivery.

Brand names
Coated VICRYL Plus
Other names
triclosan-coated suturesantibacterial-coated sutures
02

Targets

InhA

Beyond the preview

Go deeper on Vicryl Plus + Monocryl Plus + PDS Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vicryl Plus + Monocryl Plus + PDS Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call